CSPG4-targeting monoclonal antibodies (Hawthorn Pharmaceuticals)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameCSPG4-targeting monoclonal antibodies (Hawthorn Pharmaceuticals)
Drug Alias Namechondrotin sulfate proteoglycan 4 targeting monoclonal antibodies (Hawthorn Pharmaceuticals)chondrotin sulfate proteoglycan 4 targeting monoclonal antibodies (University of Pittsburgh)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionChondroitin sulfate proteoglycan 4 inhibitors
TargetsChondroitin sulfate proteoglycan 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHawthorn Pharmaceuticals IncUniversity Of Pittsburgh
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A